Revenue, last quarter
$9.2M
−69.2% vs same quarter last year
Net income
−$40.7M
+34.2% vs same quarter last year
EPS, diluted
−$0.62
+48.3% vs same quarter last year
Operating cash flow
$38.6M
+169% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $170.4M | −$193.9M |
| FY24 | $83.3M | −$227.1M |
| FY23 | $90.2M | −$263.5M |
| FY22 | $112.7M | −$280.3M |
| FY21 | $470.3M | $127.8M |
| FY20 | $154.6M | −$111.3M |
| FY19 | $35.2M | −$94.7M |
| FY18 | $218.5M | $99.9M |
| FY17 | $10.4M | −$73.2M |
| FY16 | $4.6M | −$63M |
| FY15 | $7.6M | −$22.8M |
| FY14 | $6.1M | −$4M |
| FY13 | $6.1M | −$5.4M |
| FY12 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | - | −94.6% | −113.8% |
| FY24 | 59.7% | −280% | −272.5% |
| FY23 | 58.8% | −297.1% | −292% |
| FY22 | 51.6% | −233.2% | −248.7% |
| FY21 | 89% | 34% | 27.2% |
| FY20 | 76.9% | −77.1% | −72% |
| FY19 | 76.6% | −422.9% | −268.9% |
| FY18 | 95.6% | 40.3% | 45.7% |
| FY17 | 83.6% | −730.2% | −704% |
| FY16 | 97.9% | −1423.8% | −1372.1% |
| FY15 | 98.7% | −304.9% | −300.6% |
| FY14 | 98% | −60.2% | −65.4% |
| FY13 | 97.2% | −78.5% | −88.5% |
| FY12 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$126.4M |
| FY24 | −$175.6M |
| FY23 | −$228.4M |
| FY22 | −$238.2M |
| FY21 | $134.7M |
| FY20 | −$80.9M |
| FY19 | −$119.4M |
| FY18 | $91.4M |
| FY17 | −$65.2M |
| FY16 | −$56.7M |
| FY15 | −$23M |
| FY14 | - |
| FY13 | - |
| FY12 | - |
- Regenxbio
- Healthcare median
Show the numbers
| Year | Regenxbio | Healthcare median |
|---|---|---|
| FY25 | −113.8% | −30.6% |
| FY24 | −272.5% | −47% |
| FY23 | −292% | −58% |
| FY22 | −248.7% | −80.4% |
| FY21 | 27.2% | −71.8% |
| FY20 | −72% | −62.2% |
| FY19 | −268.9% | −46.2% |
| FY18 | 45.7% | −49.6% |
| FY17 | −704% | −45.9% |
| FY16 | −1372.1% | −36% |
| FY15 | −300.6% | −37.8% |
| FY14 | −65.4% | −35.5% |
| FY13 | −88.5% | −37.1% |
| FY12 | - | −29.1% |